In this webinar, we will uncover the latest techniques in cell and gene therapy to recognize, target, and eliminate cancer cells and tumors. Our experts will examine each major type of cellular immunotherapy, from tumor-infiltrating lymphocytes (TILs) to T-cell receptor (TCR) T cells, CAR-T cells, and natural killer (NK) cells, including autologous and allogeneic options.
We will also review current challenges and opportunities within the CGT workflow for immunotherapy, including:
Additionally, we’ll take attendees through a use-case that applies best practices as we move from plasmid starting material through viral vector to gene-modified cell therapy. Last, we’ll cover what you should expect next in the immunotherapy space and how to prepare for it.